Frontotemporoparietal dementia: Clinical phenotype associated with the c.709-1G>A PGRN mutation

Neurology

Volumn 73, Issue 17, 2009, Pages 1367-1374

  Moreno, F ^a,b   Indakoetxea, B ^a,b   Barandiaran, M ^a,b   Alzualde, A ^a,b,c   Gabilondo, A ^a,b   Estanga, A ^c   Ruiz, J ^a,b   Ruibal, M ^d   Bergareche, A ^e   Marti Masso J F ^a,b   Lopez De Munain A ^a,b  

^a HOSPITAL DONOSTIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d HOSPITAL DE ZUMÁRRAGA   (Spain)

^e Medical Management of Integrated Healthcare Organization Bidasoa Bidasoa Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN;

ADULT; AGED; APATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MALE; ONSET AGE; PARIETAL LOBE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA;

ADULT; AGE OF ONSET; AGED; BRAIN DISEASES; DEPRESSION; DISEASE PROGRESSION; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MENTAL DISORDERS; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; PHENOTYPE; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; SPAIN; SYNDROME;

EID: 70350560783     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bd82a7     Document Type: Article

References (39)

1. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442: 916-919. (Pubitemid 44285946)
2. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442: 920-924. (Pubitemid 44285947)
3. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988-3001. (Pubitemid 44530703)
4. Snowden JS, Pickering-Brown SM, Mackenzie IR, et al. Progranulin gene mutations associated with frontotempo-ral dementia and progressive non-fluent aphasia. Brain 2006;129:3091-3102.
5. Bruni AC, Momeni P, Bernardi L, et al. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology 2007;69:140-147.
6. Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia. Arch Neurol 2007;64:43-47.
7. Rademackers R, Baker M, Gass J, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 14773T (Arg493X) mutation: an international initiative. Lancet Neurol 2007;6:857-868.
8. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008;131:706-720.
9. Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuro-psychological, imaging and genetic study. Brain 2008;131: 732-746.
10. López de Munain A, Alzualde A, Gorostidi A, et al. Mutations in progranulin gene: clinical, pathological, and ribo-nucleic acid expression findings. Biol Psychiatry 2008;63: 946-952.
11. Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 2008;131:721-731.
12. Kelley BJ, Haidar W, Boeve BF, et al. Prominent pheno-typic variability associated with mutations in progranulin. Neurobiol Aging 2009;30:739-751.
13. Bertranpetit J, Cavalli-Sforza LL. A genetic reconstruction of the history of the population in the Iberian Peninsula. Ann Hum Genet 1991;55:51-67.
14. Kertesz A, McMonagle P, Blair M, Davidson W, Muñoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005;128:1996-2005.
15. Knopman D, Boeve B, Caselli R, et al. Longitudinal tracking of FTLD: toward developing clinical trial methodology. Alzheimer Dis Assoc Disord 2007;21:S58-S63.
16. Folstein MF, Folstein S, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. CERAD: clinical and neuropsychological assessment of Alzheimer?s disease. Psychopharmacol Bull 1988;24:641-652.
18. Goodglass H, Kaplan E. Boston Diagnostic Aphasia Examination (BDAE). Philadelphia: Lea & Febiger; distributed by Psychological Assessment Resources, Odessa, FL; 1983.
19. Peña-Casanova J. Programa Integrado de Exploración Neu-ropsicológica: Test Barcelona. Barcelona: Masson; 1990.
20. Benton A, Hamsher K. Multilingual aphasia examination. Iowa City: University of Iowa; 1978.
21. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55: 1621-1626.
22. Hallam BJ, Jacova C, LaMarre A, et al. Executive control of attention in presymptomatic progranulin-mutation carriers. Presented at the 6th International Conference on Frontotemporal Dementias; September 5, 2008; Rotterdam, the Netherlands.
23. Van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 2008;7:965-974.
24. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007;66: 142-151.
25. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
26. Mesulam MM. Primary progressive aphasia. Ann Neurol 2001;49:425-432.
27. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54(suppl 5): S15-S19.
28. Rohrer JD, Warren JD, Omar R, et al. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 2008;65: 506-513.
29. Lendon CL, Lynch T, Norton J, et al. Hereditary dyspha-sic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 1998;50:1546-1555.
30. Mackenzie IR, Baker M, West G, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 2006;129:853-867.
31. Whitwell JL, Jack CR, Baker M, et al. Voxel-based mor-phometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranu-lin mutations. Arch Neurol 2007;64:371-376. (Pubitemid 46425691)
32. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial cortico-basal syndrome. Brain 2006;129:3115-3123.
33. Spina S, Murrell JR, Huey ED, et al. Corticobasal syndrome associated with the A9D progranulin mutation. J Neuropathol Exp Neurol 2007;66:892-900.
34. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-969.
35. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
36. Benussi L, Binetti G, Sina E, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008;29:427-435.
37. Spina S, Murrell JR, Huey ED, et al. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology 2007;68:820-827.
38. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
39. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson?s disease. Neurobiol Aging 2003;24:197-211.